Therefore, CD247 may promote inflammation in SLE by regulating the non-canonical NF-kB signaling pathway and further affect the immune microenvironment and cellular function of DLBCL based on immune cells (CD8 + T cells). This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.